PIROXICAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Piroxicam, and what generic alternatives are available?
Piroxicam is a drug marketed by Breckenridge, Cycle, Egis, Flamingo Pharms, Hikma, Ivax Sub Teva Pharms, Micro Labs, Mylan, Norvium Bioscience, Nostrum Labs Inc, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem, Watson Labs, and Zydus Lifesciences. and is included in twenty-two NDAs.
The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Piroxicam
A generic version of PIROXICAM was approved as piroxicam by TEVA on December 11th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIROXICAM?
- What are the global sales for PIROXICAM?
- What is Average Wholesale Price for PIROXICAM?
Summary for PIROXICAM
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 22 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 160 |
| Clinical Trials: | 28 |
| Drug Prices: | Drug price information for PIROXICAM |
| Drug Sales Revenues: | Drug sales revenues for PIROXICAM |
| What excipients (inactive ingredients) are in PIROXICAM? | PIROXICAM excipients list |
| DailyMed Link: | PIROXICAM at DailyMed |
Recent Clinical Trials for PIROXICAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Monastir | Phase 2 |
| Mansoura University | Phase 2 |
| Farjad Zafar | Phase 4 |
Pharmacology for PIROXICAM
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for PIROXICAM
Anatomical Therapeutic Chemical (ATC) Classes for PIROXICAM
US Patents and Regulatory Information for PIROXICAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | PIROXICAM | piroxicam | CAPSULE;ORAL | 205585-001 | Jul 17, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | PIROXICAM | piroxicam | CAPSULE;ORAL | 074131-002 | Dec 11, 1992 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Industries | PIROXICAM | piroxicam | CAPSULE;ORAL | 073536-001 | Mar 12, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms | PIROXICAM | piroxicam | CAPSULE;ORAL | 074103-001 | Aug 28, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | PIROXICAM | piroxicam | CAPSULE;ORAL | 073637-001 | Jan 28, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
